Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?

According to a November 14, 2025 SEC filing, HighVista Strategies LLC initiated a new stake in Cidara Therapeutics (NASDAQ:CDTX), acquiring 70,904 shares worth $6.79 million as of September 30, 2025. This new holding accounts for 1.66% of the fund’s reportable U.S. equity assets for the quarter. The fund reported a total of 148 reportable positions at quarter-end.This is a new position; the $6.79 million stake makes up 1.66% of HighVista Strategies LLC’s 13F reportable AUM as of September 30, 2025.Top five holdings after the filing:  Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool